A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction

A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction

ConditionPostoperative Gastrointestinal Dysfunction

Trial statusRecruiting

Trial phasePhase 2

Trial typeInterventional

Biological sexAll

Age18-75

SponsorShandong New Time Pharmaceutical Co., LTD

About this trial

This study is a multicenter, randomized, double-blind, parallel, placebo-controlled phase II clinical study.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Mosapride Citrate Injection(high)
Mosapride Citrate Injection(low)
Placebo

Treatment groups

150 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Shandong New Time Pharmaceutical Co., LTD